Rewiring transcriptional plasticity: the case for dual YAP1 and TAZ targeting in gastric cancer peritoneal metastases
Cancer Heterogeneity and Plasticity · 28.03.2026
DOI: 10.47248/chp2603010004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Heterogeneity and Plasticity, online erschienen am 28.03.2026. Verfasst von Rahul Kumar. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
As key transcriptional co-activators, YAP1 and TAZ are frequent drivers of progression across a broad spectrum of solid tumors.These mechanosensitive regulators respond to tumor microenvironmental cues to fuel essential malignant traits such as proliferation, stem cell-like plasticity, drug resistance, and metastasis [1].While normal tissues typically suppress their activity, cancers, driven by inflammation and Hippo pathway disruption, frequently exhibit sustained YAP1/TAZ signaling.Because many malignant tumors depend on this axis to maintain their aggressive phenotype, targeting YAP1 and TAZ represents a rational and high-priority therapeutic strategy [1].
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Kumar, R. (2026). Rewiring transcriptional plasticity: the case for dual YAP1 and TAZ targeting in gastric cancer peritoneal metastases. Cancer Heterogeneity and Plasticity. https://doi.org/10.47248/chp2603010004
Vancouver
Kumar R. Rewiring transcriptional plasticity: the case for dual YAP1 and TAZ targeting in gastric cancer peritoneal metastases. Cancer Heterogeneity and Plasticity. 2026. doi:10.47248/chp2603010004
BibTeX
@article{Kumar2026,
author = {Kumar, Rahul},
title = {Rewiring transcriptional plasticity: the case for dual YAP1 and TAZ targeting in gastric cancer peritoneal metastases},
journal = {Cancer Heterogeneity and Plasticity},
year = {2026},
doi = {10.47248/chp2603010004}
}
EUVIMED